×
About 8,820 results

ALLMedicine™ Liver Biopsy Center

Research & Reviews  3,093 results

Evaluation of Patients With Liver Disease
https://clinicaltrials.gov/ct2/show/NCT00001971

May 13th, 2022 - This is a general clinical research protocol to allow for evaluation, investigation and long-term follow up of patients who have an acute or chronic liver disease. The protocol is designed to study the natural history and pathogenesis of various l...

People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
https://clinicaltrials.gov/ct2/show/NCT03520660

May 13th, 2022 - We intend to enroll up to 350 subjects with chronic hepatitis C virus (HCV) infection. Subjects will be recruited from two sources: Phase I: treatment naive or experienced who have failed a prior treatment (including DAA-experienced) who are willi...

The Availability of the Enhanced Liver Fibrosis (ELF) Test Affects the Rate of Diagnosis of Nonalcoholic Steatohepatitis (NASH) With Fibrosis in Patients Referred to Hepatology
https://clinicaltrials.gov/ct2/show/NCT05370053

May 11th, 2022 - Background: During the hepatology evaluation, vibration-controlled transient elastography (VCTE) is often used as a clinical decision aid to target high-risk patients for liver biopsy. The enhanced liver fibrosis (ELF) test is expected to be appro...

Liver Graft Viability Assessment During Normothermic Regional Perfusion
https://clinicaltrials.gov/ct2/show/NCT05361044

May 10th, 2022 - With the increasing shortage of available donor organs, liver transplantation from donation after circulatory death (DCD) has been established in many countries to offer a therapeutic strategy for patients with end-stage liver disease beyond stand...

see more →

Guidelines  12 results

Non-invasive diagnosis and follow-up of benign liver tumours.
https://doi.org/10.1016/j.clinre.2021.101765
Clinics and Research in Hepatology and Gastroenterology; Nault JC, Blanc JF et. al.

Aug 2nd, 2021 - Hepatocellular benign liver tumours are mainly developed on normal liver and include hepatic hemangioma, focal nodular hyperplasia and hepatocellular adenoma from the most frequent to the less frequent. The diagnosis of hepatic hemangioma and of s...

Non-invasive diagnosis and follow-up of chronic infection with Hepatitis C Virus.
https://doi.org/10.1016/j.clinre.2021.101771
Clinics and Research in Hepatology and Gastroenterology; Tran A, Shili-Masmoudi S et. al.

Aug 1st, 2021 - Hepatitis C virus (HCV) infection is a major cause of chronic liver disease. Clinical care for patients with HCV-related liver disease has advanced considerably with developments in screening, diagnostic procedures to evaluate liver fibrosis and i...

Non-invasive diagnosis and follow-up of hyperferritinaemia.
https://doi.org/10.1016/j.clinre.2021.101762
Clinics and Research in Hepatology and Gastroenterology; Bardou-Jacquet E, Hamdi-Roze H et. al.

Aug 1st, 2021 - Increased serum ferritin is a very frequent cause of referral for which thorough evaluation is required to avoid unnecessary exploration and inaccurate diagnosis. Clinicians must thus know factors and tools that are relevant in this setting. Sever...

Non-invasive diagnosis and follow-up in liver transplantation.
https://doi.org/10.1016/j.clinre.2021.101774
Clinics and Research in Hepatology and Gastroenterology; Dumortier J, Besch C et. al.

Aug 1st, 2021 - The field of liver transplantation directly or indirectly embodies all liver diseases, in addition to specific ones related to organ rejection (cellular and humoral). The recommended non-invasive methods for determining the indication for liver tr...

Non-invasive diagnosis and follow-up of vascular liver diseases.
https://doi.org/10.1016/j.clinre.2021.101764
Clinics and Research in Hepatology and Gastroenterology; Rautou PE, Elkrief L et. al.

Aug 1st, 2021 - Vascular disorders of the liver are rare diseases, some of which are diagnosed mainly with non-invasive tests and others by liver biopsy. Non-invasive methods can be used to diagnose and monitor these diseases. However, their evaluation needs to b...

see more →

Drugs  9 results see all →

Clinicaltrials.gov  185 results

People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
https://clinicaltrials.gov/ct2/show/NCT03520660

May 13th, 2022 - We intend to enroll up to 350 subjects with chronic hepatitis C virus (HCV) infection. Subjects will be recruited from two sources: Phase I: treatment naive or experienced who have failed a prior treatment (including DAA-experienced) who are willi...

Evaluation of Patients With Liver Disease
https://clinicaltrials.gov/ct2/show/NCT00001971

May 13th, 2022 - This is a general clinical research protocol to allow for evaluation, investigation and long-term follow up of patients who have an acute or chronic liver disease. The protocol is designed to study the natural history and pathogenesis of various l...

The Availability of the Enhanced Liver Fibrosis (ELF) Test Affects the Rate of Diagnosis of Nonalcoholic Steatohepatitis (NASH) With Fibrosis in Patients Referred to Hepatology
https://clinicaltrials.gov/ct2/show/NCT05370053

May 11th, 2022 - Background: During the hepatology evaluation, vibration-controlled transient elastography (VCTE) is often used as a clinical decision aid to target high-risk patients for liver biopsy. The enhanced liver fibrosis (ELF) test is expected to be appro...

Liver Graft Viability Assessment During Normothermic Regional Perfusion
https://clinicaltrials.gov/ct2/show/NCT05361044

May 10th, 2022 - With the increasing shortage of available donor organs, liver transplantation from donation after circulatory death (DCD) has been established in many countries to offer a therapeutic strategy for patients with end-stage liver disease beyond stand...

Boramae Hospital Liver Cirrhosis Patient Cohort Study
https://clinicaltrials.gov/ct2/show/NCT01943318

May 5th, 2022 - The investigators are planning to recruit patients with liver cirrhosis, and collect the baseline clinical laboratory data. Biological tests, endoscopy,liver ultrasonography (including ARFI) and hepatic venous pressure gradient measurements will b...

see more →

News  213 results

AHA Issues First Scientific Statement on NAFLD and CVD
https://www.medscape.com/viewarticle/972172

Apr 14th, 2022 - Nonalcoholic fatty liver disease (NAFLD) is an increasingly common, underdiagnosed, and underappreciated independent risk factor for atherosclerotic cardiovascular disease (ASCVD), the American Heart Association (AHA) says in the first-ever scient...

Noninvasive ELF Test Identifies Advanced Fibrosis Risk in NAFLD
https://www.medscape.com/viewarticle/962366

Nov 5th, 2021 - A noninvasive enhanced liver fibrosis (ELF) blood test identifies patients with nonalcoholic fatty liver disease (NAFLD) who are at increased risk of advanced fibrosis, according to a new study. According to the study researchers, when combined wi...

Advanced Fibrosis Tied to Most Severe Outcomes in NAFLD
https://www.medpagetoday.com/gastroenterology/generalhepatology/95164

Oct 20th, 2021 - In patients with non-alcoholic fatty liver disease (NAFLD), advanced fibrosis was associated with a greater risk for liver decompensation and all-cause mortality compared to those with lower stages of fibrosis, a prospective cohort study found. In...

Biopsy May Not Be Needed to Treat Immune Checkpoint Inhibitor-Associated Hepatitis
https://www.medscape.com/viewarticle/960399

Oct 7th, 2021 - NEW YORK (Reuters Health) - In patients taking immune checkpoint inhibitors (ICIs) who developed moderate-to-severe liver injury, a biopsy delayed steroid initiation and was not associated with more rapid hepatitis resolution of hepatitis, an obse...

MRE Plus FIB-4 Beats FAST in Liver Fibrosis Detection
https://www.medscape.com/viewarticle/960338

Oct 6th, 2021 - A combination of magnetic resonance elastography and blood levels of fibrosis-4 index (MEFIB) outperformed FibroScan-AST (FAST) in determining the presence of significant fibrosis among patients with nonalcoholic fatty liver disease (NAFLD), accor...

see more →

Patient Education  16 results see all →